Kolexia
Carinato Helene Médecine générale
Carinato Helene
Médecine générale
Centre Paul Strauss
Strasbourg, France
20 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde de la tête et du cou Carcinome épidermoïde Carcinomes Fatigue Tumeurs du côlon Cachexie Carcinome pulmonaire non à petites cellules Tumeurs du cerveau Méningiome

Collaborateurs

Voir plus
Burgy Mickaël
Burgy Mickaël
Centre Paul Strauss, Strasbourg, France
Chiappa Pascale
Chiappa Pascale
Centre Hospitalier de Selestat, Sélestat, France
Petit Thierry
Petit Thierry
Centre Paul Strauss, Strasbourg, France
Fischbach Cathie
Fischbach Cathie
Centre Paul Strauss, Strasbourg, France

Industries

Voir plus
Servier
1 collaboration(s)
Dernière en 2021
Mylan Medical
1 collaboration(s)
Dernière en 2021
Adiral Assistance
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
676P ATHENA: A multicenter phase II of atezolizumab (A) and bevacizumab (B) in patients (pts) with recurrent or metastatic squamous-cell carcinoma of the head and neck (R/M HNSCC) - The HPV-negative cohort
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Frontiers in oncology   27 octobre 2021
930P Weekly paclitaxel, carboplatin and cetuximab (PCC) as first-line treatment of recurrent and/or metastatic head & neck squamous cell carcinoma (R/M-HNSCC) for patients ineligible to cisplatin based chemotherapy
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol.
Frontiers in oncology   07 août 2020
PROTECT-01: Evolution of the Physical Condition in Treated Cancer Patients
Essai Clinique (Centre Paul Strauss)   10 février 2020
Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.
World journal of surgical oncology   16 avril 2019
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Oncotarget   25 décembre 2018
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}